Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX

Journal of Acquired Immune Deficiency Syndromes

Volumn 48, Issue 1, 2008, Pages 114-116

  Venhoff, Nils ^a   Venhoff, Ana C ^a   Jayewardene, Anura L ^b   Aweeka, Fran ^b   Lebrecht, Dirk ^a   Walker, Ulrich A ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NUCLEOMAXX; PLACEBO; URIDINE; ZIDOVUDINE;

AREA UNDER THE CURVE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LETTER; MAXIMUM PLASMA CONCENTRATION; MITOCHONDRIAL TOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS RESISTANCE;

EID: 42649097252     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318160a67d     Document Type: Letter

References (13)